FDA electronic MDR reporting workshop scheduled for January 25, 1996.
This article was originally published in The Gray Sheet
Executive SummaryDEVICE ADVERSE EVENT ELECTRONIC REPORTING WORKSHOP SCHEDULED FOR JAN. 25 is designed to provide FDA with industry input on its plans to implement an electronic medical device reporting system in 1997. The session in Gaithersburg, Maryland will include presentations from FDA, industry, user facilities and electronic data interchange (EDI) vendors, as well as a "forum" for interested parties "to discuss their ideas, desires, and needs regarding electronic report submission," the agency says.
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.